The Food and Drug Administration approved the first-ever weight-loss pill on Monday, a move that is set to greatly expand the industry.

Novo Nordisk’s GLP-1 weight-loss pill is a tablet formulation of the popular Ozempic and Wegovy. The drugs previously could only be taken via injection, a discomforting method for many users. Its transformation into a convenient pill is almost certain to lead to increased usage of the drug.

Recommended Stories

Ozempic and Wegovy linked to gastrointestinal problems in new research

Wonderful or worrisome? What to know about new weight loss drugs

Berberine: Experts warn ‘nature’s Ozempic’ not worth its weight